APA (7th ed.) Citation

Peterfy, C., Dicarlo, J., Emery, P., Genovese, M., Keystone, E., Taylor, P., . . . Macias, W. (2019). Use of magnetic resonance imaging to support dose selection in a phase II trial of baricitinib combined with conventional synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis. Journal of Rheumatology.

Chicago Style (17th ed.) Citation

Peterfy, C., et al. Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 2019.

MLA (9th ed.) Citation

Peterfy, C., et al. Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 2019.